76
Participants
Start Date
April 30, 2006
Primary Completion Date
July 31, 2008
Study Completion Date
January 31, 2009
Amrubicin
Amrubicin 40mg/m\<2\> IV days 1, 2, 3 of each 21-day cycle until disease progression.
Topotecan
Topotecan 1.5mg/m\<2\> IV days 1, 2, 3, 4, 5 of each 21-day cycle until disease progression.
New York Oncology Hematology, PC, Albany
SUNY Upstate Medical University - Regional Oncology Center, Syracuse
Medical Oncology Associates, Kingston
Maryland Oncology Hematology, PA, Columbia
Alliance Hematology Oncology, PA - Carroll County Cancer Center, Westminster
Sinai Hospital of Baltimore, Baltimore
Johns Hopkins Hospital - The Bunting Blaustein Cancer Research Building, Baltimore
Virginia Oncology Associates, Norfolk
Oncology & Hematology Associates of SW Virginia, Inc., Salem
Cancer Centers of North Carolina, Raleigh
Northwestern Carolina Oncology & Hematology, Hickory
Cancer Centers of the Carolinas, Greenville
John B. Amos Cancer Center, Columbus
Ocala Oncology Center, Ocala
Cancer Centers of Florida, PA, Ocoee
Birmingham Hematology & Oncology, Birmingham
Norton Healthcare - Louisville Oncology, Louisville
Central Indiana Cancer Centers, Indianapolis
Hope Center, Terre Haute
Minnesota Oncology Hematology, PA, Minneapolis
Cancer Care & Hematology Specialists of Chicago, Niles
Oncology & Hematology of Central Illinois, Peoria
Blessing Cancer Center, Quincy
Hematology/Oncology Consultants, St Louis
Arch Medical Services - Center for Cancer Care & Research, St Louis
St. Joseph Oncology, Inc., Saint Joseph
Missouri Cancer Associates, Columbia
Texas Oncology, PA, Dallas
Texas Oncology - Sammons Cancer Center, Dallas
Tyler Cancer Center, Tyler
Texas Oncology, PA, Fort Worth
Texas Oncology Cancer Care & Research Center, Waco
Texas Oncology, PA - Deke Slayton Cancer Center, Webster
Texas Oncology Cancer Center, Austin
Alison Cancer Center, Midland
West Texas Cancer Center, Odessa
Rocky Mountain Cancer Center - Sky Ridge, Lone Tree
Rocky Mountain Cancer Center - Denver, Denver
Hematology Oncology Associates, Phoenix
Comprehensive Cancer Centers of Nevada, Las Vegas
Moores UCSD Cancer Center, La Jolla
Alta Bates Medical Center - Comprehensive Cancer Center, Berkeley
Northwest Cancer Specialists, Portland
Willamette Valley Cancer Center, Eugene
Puget Sound Cancer Center, Seattle
Northwest Cancer Specialists - Vancouver Cancer Center, Vancouver
Texas Cancer Center at Medical City, Dallas
Lead Sponsor
Celgene Corporation
INDUSTRY